Key Findings:  Following the cannabis treatment, behavioral outbreaks were much improved or very much improved in 61% of patients. This preliminary study supports feasibility of CBD-based cannabis trials in children with ASD.
Type of Study:  Clinical Trial
Study Sample Size:  60
Study Result:  Positive
Research Location(s):  Israel
Year of Pub:  2019
Cannabinoids Studied:  Cannabidiol (CBD), Tetrahydrocannabinol (THC)
Phytocannabinoid Source:  Unspecified
Chemotype:  Chemotype III
Citation:  Aran A, et al. Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems-A Retrospective Feasibility Study. J Autism Dev Disord. 2019; 49:1284-1288. doi: 10.1007/s10803-018-3808-2
Authors:  Aran A, Cassuto H, Lubotzky A, Wattad N, Hazan E